Search

Qingxin Mu

from Seattle, WA
Age ~42
Get Report
Also known as:
Qiengxin Mu, Mu Qingxin
Related to:
M U Qingxin
Connected to:
Alvin Mu, 27Amy D Mu, 41Anthony U Mu, 30Ayeaye A Mu, 54Cixiu Mu, 77Elizabeth Y Mu, 31Emily Mu, 25Eva Mu, 43Ja K Mu, 80Jade Mu, 69

Qingxin Mu Phones & Addresses

  • Seattle, WA
  • Lawrence, KS
  • 1113 Natchez Pt APT 94, Memphis, TN 38103

Work

Company: University of kansas Jan 2012 Position: Post doctoral researcher

Education

Degree: Ph.D. School / High School: Shandong University 2005 to 2010 Specialities: Nanomedicine

Skills

Protein Expression • Cell Culture • Western Blotting • Biochemistry • Drug Discovery • Confocal Microscopy • Cell • Qpcr • Fluorescence Spectroscopy • Flow Cytometry • Molecular Biology • Carbon Nanotubes • Protein Purification • Nanoparticles • Cell Biology • Hplc • Nanomedicine • High Throughput Screening • Characterization • High Performance Liquid Chromatography • Nanotoxicology • Size Exclusion Chromatography • Confocal Laser Scanning Microscopy • Zeta Potential

Languages

English • Mandarin

Interests

Science and Technology • Health

Industries

Research

Resumes

Resumes

Qingxin Mu Photo 1

Research Scientist 3

View page
Location:
Seattle, WA
Industry:
Research
Work:
University of Kansas since Jan 2012
Post Doctoral Researcher
St. Jude Children's Research Hospital Aug 2010 - Jan 2012
Postdoctoral Research Associate
St. Jude Children's Research Hospital Jun 2007 - Oct 2009
International Research Schloar
Education:
Shandong University 2005 - 2010
Ph.D., Nanomedicine Henan University 2001 - 2005
B.S., Pharmaceutics
Skills:
Protein Expression
Cell Culture
Western Blotting
Biochemistry
Drug Discovery
Confocal Microscopy
Cell
Qpcr
Fluorescence Spectroscopy
Flow Cytometry
Molecular Biology
Carbon Nanotubes
Protein Purification
Nanoparticles
Cell Biology
Hplc
Nanomedicine
High Throughput Screening
Characterization
High Performance Liquid Chromatography
Nanotoxicology
Size Exclusion Chromatography
Confocal Laser Scanning Microscopy
Zeta Potential
Interests:
Science and Technology
Health
Languages:
English
Mandarin

Publications

Us Patents

Iron Oxide Nanoparticle For Targeted Chemo-Immunotherapy

View page
US Patent:
20230067643, Mar 2, 2023
Filed:
Aug 23, 2022
Appl. No.:
17/821794
Inventors:
- Seattle WA, US
Qingxin Mu - Seattle WA, US
Guanyou Lin - Seattle WA, US
Assignee:
University of Washington - Seattle WA
International Classification:
A61K 47/69
A61P 35/00
A61K 47/60
A61P 35/04
Abstract:
Multifunctional nanoparticle for targeted therapeutic drug delivery, comprising (a) an iron oxide core having silica-polyethylene glycol coupled thereto to provide an iron oxide coated core, (b) a cytotoxic agent reversibly associated with the coated core; (c) an immunomodulating agent reversibly associate with the coated core; and (d) a tumor targeting agent associated with the coated core. Methods for using the nanoparticle to treat cancers and methods for making the nanoparticle.
Control profile
Qingxin Mu from Seattle, WA, age ~42 Get Report